Evidence map›Paper›PMID 26506362›Full record

ReviewMarine drugs2015

Cell Death Inducing Microbial Protein Phosphatase Inhibitors--Mechanisms of Action.

Rune Kleppe, Lars Herfindal, Stein Ove Døskeland

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Current research in pharmacology and drug discovery · 2022
    Article
  2. Article
  3. Article
  4. Microcystin-LR induced liver injury in mice and in primary human hepatocytes is caused by oncotic necrosis.Toxicon : official journal of the International Society on Toxinology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rune KleppeDepartment of Biomedicine, University of Bergen, Jonas Lies vei 81, N-5009 Bergen, Norway. rune.kleppe@uib.no.
Lars HerfindalDepartment of Biomedicine, University of Bergen, Jonas Lies vei 81, N-5009 Bergen, Norway. lars.herfindal@uib.no.
Stein Ove DøskelandDepartment of Biomedicine, University of Bergen, Jonas Lies vei 81, N-5009 Bergen, Norway. stein.doskeland@uib.no.
University of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Okadaic acid (OA) and microcystin (MC) as well as several other microbial toxins like nodularin and calyculinA are known as tumor promoters as well as inducers of apoptotic cell death. Their intracellular targets are the major serine/threonine protein phosphatases. This review summarizes mechanisms believed to be responsible for the death induction and tumor promotion with focus on the interdependent production of reactive oxygen species (ROS) and activation of Ca(2+)/calmodulin kinase II (CaM-KII). New data are presented using inhibitors of specific ROS producing enzymes to curb nodularin/MC-induced liver cell (hepatocyte) death. They indicate that enzymes of the arachidonic acid pathway, notably phospholipase A2, 5-lipoxygenase, and cyclooxygenases, may be required for nodularin/MC-induced (and presumably OA-induced) cell death, suggesting new ways to overcome at least some aspects of OA and MC toxicity.

Indexed as

AnimalsApoptosisCarcinogensCell DeathEnzyme InhibitorsHumansMarine ToxinsMicrocystinsOkadaic AcidOxazolesPeptides, CyclicPhosphoprotein PhosphatasesReactive Oxygen Speciescalyculin ACarcinogensEnzyme InhibitorsMarine ToxinsmicrocystinMicrocystinsnodularinOkadaic AcidOxazolesPeptides, CyclicPhosphoprotein PhosphatasesReactive Oxygen Speciesapoptosiscell deathinhibitormicrocystinnodularinokadaic acidprotein phosphatase

Identifiers

PMID26506362
PMCPMC4626703
OpenAlexW1810523969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.